TPLKF yields 5.92% · JNJ yields 2.13%● Live data
📍 JNJ pulled ahead of the other in Year 10
Combined, TPLKF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of TPLKF + JNJ for your $10,000?
PVA TePla AG, together with its subsidiaries, manufactures and sells systems for the production and refinement of high-tech materials worldwide. It operates through two segments, Industrial Systems and Semiconductor Systems. The Industrial Systems division provides structural material technologies for semiconductor, aviation and aerospace, energy technology, and hard metal tools industries; and engages in the vacuum brazing, vacuum heat treatment, and diffusion bonding activities. The Semiconductor Systems division offers crystal growing systems, including silicon wafer technologies for microelectronics and silicon carbide wafer technologies for high-performance electronics; metrology systems comprising technologies for non-destructive quality control of wafers, semiconductor parts, and high-tech industrial material; and plasma systems, such as production technologies for micro-electronic mechanical systems and high-brightness light-emitting diodes, as well as technologies for the fabrication of ultrathin wafers. The company is headquartered in Wettenberg, Germany.
Full TPLKF Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.